F-10/A 1 m55271fv10za.htm F-10/A fv10za
As filed with the Securities and Exchange Commission on May 11, 2009
Registration No. 333-140039
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Post-Effective Amendment No. 1 to
FORM F-10
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
 
BELLUS HEALTH INC.
(Exact name of Registrant as specified in its charter)
 
         
Canada
(Province or other jurisdiction of
incorporation or organization) 		  2834
(Primary Standard Industrial
Classification Code Number) 		  Not Applicable
(I.R.S. Employer
Identification No.)
275 Armand-Frappier Boulevard
Laval, Québec H7V 4A7, Canada
(450) 680-4500
(Address and telephone number of Registrant’s principal executive offices)
 
CT Corporation System
111 Eighth Avenue, 13th Floor
New York, New York 10011
(212) 894-8400
(Name, address (including zip code) and telephone number (including area code) of agent for service in the United States)
 
Copies to:
     
David Skinner, Esq.
BELLUS Health Inc.
275 Armand-Frappier Boulevard
Laval, Québec H7V 4A7, Canada
(450) 680-4500 		  Bonnie J. Roe, Esq.
Scott M. Tayne, Esq.
Davies Ward Phillips & Vineberg LLP
625 Madison Avenue, 12th Floor
New York, NY 10022
(212) 588-5500
 
 
 

 

 

Deregistration of Securities
This Post-Effective Amendment No. 1 to the Registration Statement on Form F-10 (No. 333-140039) of BELLUS Health Inc. (the “Registrant”), a corporation formerly known as Neurochem Inc., is being filed for the sole purpose of removing from registration all securities registered on such Registration Statement that remain unsold as of the date hereof, and all such unsold securities are hereby removed from registration.

2

 

SIGNATURES
     Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Post-Effective Amendment No. 1 to the Registration Statement on Form F-10 to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Laval, Province of Quebec, Country of Canada, on this 11th day of May, 2009.
         
  BELLUS HEALTH INC.
 		  
  By:   /s/ David Skinner    
    Name:   David Skinner   
    Title:   Vice President, General Counsel and
Corporate Secretary 		  
 
     Pursuant to the requirements of the Securities Act, this Post-Effective Registration Statement on Form F-10 has been signed by the following persons in the capacities indicated on this 11th day of May, 2009.
     
Name   Title
     
/s/ Francesco Bellini *
 
Francesco Bellini, Ph.D.		   Chairman, President, Chief Executive Officer and Director
(Principal Executive Officer)
/s/ Mariano Rodriguez
 
Mariano Rodriguez		   Vice President, Finance and Chief Financial Officer
(Principal Financial and Accounting Officer)
/s/ Colin Bier *
 
Colin Bier, Ph.D.		   Director
/s/ André Desmarais *
 
André Desmarais		   Director
/s/ Neil Flanzraich *
 
Neil Flanzraich		   Director and Authorized Representative in the United States
/s/ Peter Kruyt *
 
Peter Kruyt		   Director
/s/ François Legault *
 
François Legault		   Director
/w/ John Molloy *
 
John Molloy		   Director
/s/ Graeme K. Rutledge *
 
Graeme K. Rutledge		   Director
/s/ Emil Skamene *
 
Dr. Emil Skamene		   Director
       
   
* By:   /s/ David Skinner    
  Name:   David Skinner   
  As Attorney-in-fact   
 

3